Oralair

Allergen Extract From Pollen, the active ingredient in Oralair, is an allergen immunotherapy presented as a sublingual tablet for oral use. It targets grass pollen‑induced allergic rhinitis and related respiratory allergies in sensitised individuals. GNH USA supplies Oralair as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Oralair as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Oralair is an allergen immunotherapy that addresses grass‑type pollen allergy pathways: - Seasonal allergic rhinitis: reduces symptom severity and medication need during grass pollen season. - Allergic conjunctivitis: alleviates eye irritation linked to grass pollen exposure. - Mild to moderate asthma associated with grass pollen sensitivity: contributes to better airway control. - Preventive allergy management: supports long‑term tolerance development to grass pollen allergens. - Adjunct to pharmacologic therapy: enhances overall control when used with standard antihistamines or inhalers. - Immunotherapy for children : provides a non‑injectable option for pediatric patients with grass pollen allergy.

Oralair may cause local and systemic reactions following sublingual exposure.

Common Side Effects: - Oral itching or mild irritation of the mouth. - Throat discomfort or mild soreness. - Ear or facial itching. - Mild nasal congestion. - Transient hoarseness. - Mild gastrointestinal upset.

Serious or Rare Side Effects: - Systemic anaphylaxis requiring emergency treatment. - Severe bronchospasm or asthma exacerbation. - Laryngeal edema with breathing difficulty. - Persistent high‑grade urticaria. - Angio‑edema of the lips or tongue. - Unexplained drop in blood pressure (hypotension).

Before initiating Oralair, consider the following precautions: - Medical evaluation: confirm diagnosis of grass‑pollen allergy and suitability for sublingual immunotherapy. - Asthma control: ensure asthma is well‑controlled before starting treatment. - Concomitant medications: review antihistamines, beta‑agonists, or immunosuppressants for potential interaction. - Pregnancy and lactation: discuss risks and benefits with a healthcare professional. - Age restrictions: product is indicated for patients aged 5 years and older. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Oralair can interact with other medications that influence immune response or allergic reactivity.

Major Interactions (Avoid): - Beta‑beta ​  ");

Minor ");eta  ");

"  " "" "" "" " " " "" " " " "" "" " " " " " " "" ".

Moderate \\